Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Huang, Lei ^a   Xu, Aman ^a   Li, Tuanjie ^a   Han, Wenxiu ^a   Wu, Shanshan ^a   Wang, Yangyi ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer antigen 72 4; Distal gastrectomy; Gastric carcinoma; Gastric juice; Perioperative

Indexed keywords

CANCER ANTIGEN 72 4; TUMOR ANTIGEN; UNCLASSIFIED DRUG; CA-72-4 ANTIGEN; CA 72 4 ANTIGEN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; FEMALE; GASTRECTOMY BILLROTH I; GASTRODUODENOSTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH JUICE; STOMACH WALL; TUMOR VOLUME; GASTRECTOMY; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; STOMACH TUMOR;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; FEMALE; GASTRECTOMY; GASTRIC JUICE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH; STOMACH NEOPLASMS;

EID: 84879470342     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0651-3     Document Type: Article

References (29)

1. Shin HR, Carlos MC, Varghese C. Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol. 2012;42:867-81.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
3. Wang W, Li YF, Sun XW, et al. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer. 2010;29: 923-30.
4. Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125:666-73.
5. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439-49.
6. Costamagna G, Cesaro P. Early gastric cancer: detection and endoscopic treatment. Ann Ital Chir. 2012;83:183-91.
7. Moghimi-Dehkordi B, Safaee A, Ghiasi S, Zali MR. Survival in gastric cancer patients: univariate and multivariate analysis. East Afr J Public Health. 2009;6(Suppl):41-4.
8. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-90.
9. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11: 136-46.
10. Abbott DE, Margaryan NV, Jeruss JS, et al. Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther. 2010;9:23-30.
11. Yu X, Luo L, Wu Y, et al. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol. 2013;30:365.
12. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am. 1994;8:533-53.
13. Kornek GV, Depisch D, Rosen HR, et al. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. J Cancer Res Clin Oncol. 1992; 118:318-20.
14. Guadagni F, Roselli M, Amato T, et al. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res. 1992;52: 1222-7.
15. Hamazoe R, Maeta M, Matsui T, et al. CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer. Eur J Cancer. 1992;28A:1351-4.
16. Rapellino M, Piantino P, Pecchio F, et al. Disappearance curves of tumor markers after radical surgery. Int J Biol Markers. 1994; 9:33-7.
17. Tocchi A, Costa G, Lepre L, et al. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol. 1998;124: 450-5.
18. Chen XZ, Zhang WK, Yang K, et al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep. 2012;39:9031-9.
19. Emoto S, Ishigami H, Yamashita H, et al. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer. 2012;15:154-61.
20. Kim DH, Oh SJ, Oh CA, et al. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol. 2011;104:585-91.
21. Li Y, Yang Y, Lu M, Shen L. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology. 2011;58:2166-70.
22. Emanuel EJ. Reconsidering the declaration of Helsinki. Lancet. 2013;381:1532-3.
23. Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178.
24. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077-9.
25. Chen S, Feng XY, Li YF, et al. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. J Surg Oncol. 2013; 107:641-5.
26. Hakama M, Stenman UH, Knekt P, et al. Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. J Med Screen. 1994;1:60-4.
27. Suh YS, Han DS, Kong SH, et al. Laparoscopy-assisted pyloruspreserving gastrectomy is better than laparoscopy-assisted distal gastrectomy for middle-third early gastric cancer. Ann Surg. 2013. doi:10.1097/SLA. 0b013e318294d142.
28. Eom DW, Kang GH, Han SH, et al. Gastric micropapillary carcinoma: a distinct subtype with a significantly worse prognosis in TNM stages I and II. Am J Surg Pathol. 2011;35:84-91.
29. Li F, Zhang R, Liang H, et al. The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer. J Cancer Res Clin Oncol. 2012;138:111-7.